Zimmer Biomet (NYSE: ZBH) executive Desai Chintan files initial Form 3
Rhea-AI Filing Summary
Zimmer Biomet Holdings, Inc. executive Desai Chintan, serving as President, APAC, filed an initial Form 3 as a reporting person. The report lists no stock transactions, holdings entries, or derivative positions for Zimmer Biomet securities in the structured data provided.
Positive
- None.
Negative
- None.
Key Figures
Reported buy transactions: 0
Reported sell transactions: 0
Reported derivative transactions: 0
3 metrics
Reported buy transactions
0
Aggregate buy transactions in the Form 3 transaction summary
Reported sell transactions
0
Aggregate sell transactions in the Form 3 transaction summary
Reported derivative transactions
0
Aggregate derivative transactions in the Form 3 transaction summary
Key Terms
Rule 10b5-1, beneficial ownership, derivative securities
3 terms
Rule 10b5-1 regulatory
"Footnotes may reference Rule 10b5-1 trading plans"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
beneficial ownership financial
"Form 3 is an initial statement of beneficial ownership of securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
derivative securities financial
"derivativeSummary contains remaining derivative securities positions"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the ZBH Form 3 for Desai Chintan disclose?
It identifies Desai Chintan, President, APAC of Zimmer Biomet, as a reporting person on an initial Form 3. The structured data show no stock transactions, holdings entries, or derivative positions reported for Zimmer Biomet securities in this ownership statement.
Is Desai Chintan a director or 10% owner of ZBH?
No. The Form 3 lists Desai Chintan as an officer (President, APAC), not a director, and indicates he is not a ten percent owner of Zimmer Biomet Holdings, Inc., based on the reported classification fields.
Does the ZBH Form 3 report any stock purchases or sales?
No. The transaction summary in the Form 3 shows zero buy transactions and zero sell transactions, with no reported acquisitions, dispositions, or other trades in Zimmer Biomet common stock by Desai Chintan in this report.
Are any derivative securities reported for Desai Chintan in the ZBH Form 3?
No. The derivativeSummary section is empty and the transaction summary shows zero derivative transactions, indicating no options or other derivative positions are reported for Desai Chintan in this initial ownership statement.
What is Desai Chintan's role at Zimmer Biomet (ZBH) according to the Form 3?
The Form 3 identifies Desai Chintan as an officer of Zimmer Biomet with the title President, APAC. He is not listed as a director and is not classified as a ten percent owner in the ownership categories.